Corvus Pharmaceuticals CRVS Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Corvus Pharmaceuticals's total assets?
- Corvus Pharmaceuticals (CRVS) reported total assets of $253.2M in Q1 2026.
- How has Corvus Pharmaceuticals's total assets changed year-over-year?
- Corvus Pharmaceuticals's total assets increased by 326.0% year-over-year, from $59.44M to $253.2M.
- What is the long-term trend for Corvus Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's total assets has grown at a -3.6% compound annual growth rate (CAGR), from $85.53M to $71.12M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.